Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation.

MLA

Ragab, Ahmed, et al. “Explore New Quinoxaline Pharmacophore Tethered Sulfonamide Fragments as in Vitro α-Glucosidase, α-Amylase, and Acetylcholinesterase Inhibitors with ADMET and Molecular Modeling Simulation.” Drug Development Research, vol. 85, no. 4, June 2024, p. e22216. EBSCOhost, https://doi.org/10.1002/ddr.22216.

APA

Ragab, A., Salem, M. A., Ammar, Y. A., Aboulthana, W. M., Helal, M. H., & Abusaif, M. S. (2024). Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation. Drug Development Research, 85(4), e22216. https://doi.org/10.1002/ddr.22216

Chicago

Ragab, Ahmed, Mohamed A Salem, Yousry A Ammar, Wael M Aboulthana, Mohamed H Helal, and Moustafa S Abusaif. 2024. “Explore New Quinoxaline Pharmacophore Tethered Sulfonamide Fragments as in Vitro α-Glucosidase, α-Amylase, and Acetylcholinesterase Inhibitors with ADMET and Molecular Modeling Simulation.” Drug Development Research 85 (4): e22216. doi:10.1002/ddr.22216.